n-3 polyunsaturated fatty acids (PUFAs) possess several effects that may potentially reduce the risk of ischaemic heart disease. The results from clinical trials with n-3 PUFAs give rise to some optimism, and the possible value of n-3 PUFAs in the prevention and treatment of ischaemic heart disease should be further investigated.